Koyfin Home > Directory > Health Care > Intellia Thera CS > EBIT

Intellia Thera CS EBIT Chart (NTLA)

Intellia Thera CS annual/quarterly EBIT from 2014 to 2020. Earnings before interest and taxes measures the profit a company generates from its operations, making it synonymous with operating profit. By ignoring tax and interest expenses, it focuses solely on a company's ability to generate earnings from operations, ignoring variables such as the tax burden and capital structure.
  • Intellia Thera CS EBIT for the quarter ending September 09, 2020 was $-28m a -5.94% increase of 2m year over year
  • Intellia Thera CS EBIT for the last 12 months ending September 09, 2020 was $-124m a 14.19% decrease of -18m year over year
  • Intellia Thera CS Annual EBIT for 2019 was $-106m a 14.57% decrease of -15m from 2018
  • Intellia Thera CS Annual EBIT for 2018 was $-91m a 23.46% decrease of -21m from 2017
  • Intellia Thera CS Annual EBIT for 2017 was $-70m a 53.76% decrease of -37m from 2016
Other Income Statement Metrics:
  • Intellia Thera CS EBITDA for the quarter ending December 12, 2018 was $-20m a -9.31% increase of 2m year over year
  • Intellia Thera CS Net Income for the quarter ending December 12, 2018 was $-19m a -12.01% increase of 2m year over year
  • Intellia Thera CS Total Revenue for the quarter ending September 09, 2018 was $7m a 9.99% increase of 1m year over year
View Chart On Koyfin

Quarterly NTLA EBIT Data

09/2020$-28m
06/2020$-33m
03/2020$-33m
12/2019$-30m
09/2019$-25m
06/2019$-27m
03/2019$-24m
12/2018$-21m
09/2018$-24m
06/2018$-24m

Annual NTLA EBIT Data

2019$-106m
2018$-91m
2017$-70m
2016$-32m
2015$-13m
2014$-5m